Paola Nicoli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Combinatorial targeting of MYC/BCL2-associated vulnerabilities in high-grade B-cell lymphoma.
Journal: British journal of haematology
Published: February 25, 2025
Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge.
Journal: Journal of clinical medicine
Published: February 02, 2023
Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma.
Journal: EMBO molecular medicine
Published: September 19, 2022
Actionable Genetic Screens Unveil Targeting of AURKA, MEK, and Fatty Acid Metabolism as an Alternative Therapeutic Approach for Advanced Melanoma.
Journal: The Journal of investigative dermatology
Published: July 08, 2022
Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis.
Journal: Life science alliance
Published: December 17, 2021
Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis.
Journal: Developmental cell
Published: March 16, 2020
Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage.
Journal: PLoS genetics
Published: March 02, 2018
Co-optation of Tandem DNA Repeats for the Maintenance of Mesenchymal Identity.
Journal: Cell
Published: August 30, 2017
L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.
Journal: Genome research
Published: August 22, 2017
Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.
Journal: Science translational medicine
Published: May 31, 2017
Last Updated: 09/26/2026